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Abstract
It is well known that there exists a bi-directional communication system 
between the enteric nervous system and central nervous system. Recent research 
has attempted to understand the influence of intestinal bacteria on the brain and 
behavior. In this manner, it has been observed that pathogenic bacterial products 
such as lipopolysaccharides (LPSs) can induce behavioral changes such as acute 
anxiety, depressive symptoms, cognitive deficits, and increased sensitivity to vis-
ceral pain. The modulation of LPS production through probiotics, prebiotics, and 
symbiotics can prevent these changes. In addition to the neuronal, endocrine, and 
metabolic pathways, it has been observed that the immune mechanism also exerts 
an influence on the gut-brain axis. The cells of the immune system can undergo 
phenotypic changes by the induction of certain bacterial species, which can have an 
important participation in the development of brain disorders. Although the main 
effect of prebiotics is through the stimulation of probiotic bacteria, in this chapter, 
we review the indirect therapeutic potential of prebiotics on the brain through 
the intestinal microbiota, the gut-associated lymphoid tissue (GALT), and other 
components of the intestinal lumen. Thus, the objective is to elucidate the mecha-
nisms underlying its effects on the gut-brain axis. Here, we will summarize the 
possible therapeutic effect of prebiotics on intestinal microbiota, the gut-associated 
lymphoid tissue (GALT), and brain.
Keywords: prebiotics, gut microbiota, central nervous system, enteric nervous 
system, GALT
1. Introduction
The intestinal microbiota contributes significantly to metabolic, trophic, and 
protective functions. In this regard, intestinal bacteria are responsible for metabo-
lism of many complex substances into simple components; thus, intestinal microbi-
ota contributes to the digestion of nutrients and has a key role in the nutrition of the 
host, to the control of certain pathogens and to the improvement of the functions 
of the local immune system, preventing or participating in some pathologies such 
as colon cancer [1]. In addition, intestinal bacteria are involved in vitamin synthesis 
and also in ion absorption [2, 3]. Through their trophic effect, the intestinal bacteria 
stimulate the proliferation and differentiation of cells on intestinal epithelium [4]; 
also, these bacteria may contribute to the maturation of immune cells, regulating 
the proliferation of pathogenic microorganisms and their toxins [1]. In addition 
Prebiotics and Probiotics - Potential Benefits in Nutrition and Health
2
to the functions above described, it has been proposed that intestinal microbiota 
exerts indirect functions in other organs such as the liver and brain. Studies per-
formed in humans and in animal models suggest that intestinal dysbiosis has an 
important role in the development of mood disorders such as depression, anxiety, 
and Parkinson’s disease [5–7]. For these reasons, the interest in exploring the inter-
actions between immune system, intestinal microbiota, and central nervous system 
(CNS) has increased (Figure 1).
On the other hand, when bacterial probiotics are administered in adequate 
amounts, they confer benefits on host health. The main functions of probiotics are 
to prevent and ameliorate several digestive and allergic disorders. Also, the micro-
biota modulates ontogeny and immune system functions, as well as the interactions 
of the intestine-brain axis to regulate some neurological functions. However, the 
microbiota effects are not only in intestine but also in peripheral tissues, such as 
in immune system modulation and interacting with the gut-brain axis to regulate 
some neurologic functions.
2. The gut-associated lymphoid tissue (GALT)
2.1 Anatomy and physiology
The gut-associated lymphoid tissue (GALT) is a specialized component of 
mucosal-associated lymphoid tissue (MALT) or mucosal immune system that 
protects the individual’s intestine from invading pathogens. The intestine-associated 
Figure 1. 
Microbiota-GALT-brain axis. The vagus nerve makes the connection of the intestine to the brain and vice 
versa. Dysbiosis causes local alterations in the GALT and in the brain. When there is no dysbiosis, the bacterial 
metabolites participate in the state of local and systemic health and even more so over the brain.
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tissue extends throughout the small and large intestine, covering an area of  
260–300 m2 approximately. An important function of intestine is nutrient absorp-
tion, where an epithelial cells monolayer (also called enterocytes) separates the 
GALT from lumen and its content. The enterocytes monolayer on luminal surface 
is coated by a glucocalix layer, which protects them from acidic pH. The intestinal 
mucosal surface can function as a permeable barrier to the inside of the body. This 
permeability increases the vulnerability to infections by a variety of infectious agents 
that invade the human body orally. Therefore, the largest populations of plasma 
cells that produce antibodies are enriched on GALT, generating a local and systemic 
humoral immune response with high production of immunoglobulin A (IgA), pro-
moting a robust cellular immunity with cytotoxic, regulatory, and memory functions 
[8]. GALT can be divided into: (a) inductive sites, composed by lymphoid aggregates 
or follicles, and (b) effectors sites formed by the lamina propria and the lumen.
In Figure 2 there is a complete description of GALT, thus GALT forms nodules 
disseminated into the submucosa and the lamina propria. The largest aggregates 
form “Peyer’s patches,” which in the small intestine are located in front of the mes-
enteric tissue. Locally, new epithelial cells derived from stem cells are constantly 
produced to regenerate the epithelium. In addition to conventional enterocytes, 
there are also Paneth cells at the bottom of the epithelial crypts. These cells secrete 
lysozyme and other antibacterial substances to control the growth of pathogens. 
These cells are found in the small intestine, especially in the jejunum, and their 
granules become visible after several hours of fasting. Also, the mucus goblet cells 
are scattered between other cell types. On the other hand, enteroendocrine cells 
produce polypeptides and are distributed diffusely throughout the gastrointestinal 
tract. On the surface of Peyer’s patches, “M cells” also called “caveolate cells” are 
located, which capture antigens and function as intestinal chemoreceptors.
Beneath the epithelial lining is an underlying layer of connective tissue called 
lamina propria, which is connected to the lymphatic circulation and mesenteric 
Figure 2. 
Anatomy of gut-associated lymphoid tissue (GALT).
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lymph nodes. The intestine is constantly exposed to several antigens derived from 
the diet, microbiota, and a wide variety of bacterial, viral, fungal, and other patho-
gens. The immunity of this compartment is highly specialized because it is capable 
of both functions: (a) triggering an immune response and (b) inducing tolerance 
by suppressing immune response through the interaction of epithelial cells and 
microbiota [9, 10].
The induction of intestinal mucosa tolerance depends on several factors, such 
as: (a) nature of antigen (mainly protein antigens) [11]; (b) dose and frequency 
of antigen exposition [12–14]; (c) kinetics of antigen uptake, because antigenic 
exposition time with the immune system is key to induce tolerance [15]; and (d) 
genetic background and age of the host, because there is different susceptibility 
to infection, depending on age and genetic inheritance. The main antigens reach-
ing GALT are a mixture of free amino acids and short oligopeptides, generated by 
gastric, pancreatic, or protease action on large proteins, which are absorbed by 
intestinal epithelial cells [16]. However, some intact proteins or incomplete prote-
olysis products can reach inductive sites through the following three non-exclusive 
pathways:
a. The epithelium responds to stimuli from different antigens expressing 
chemokine and cytokine genes [17]. Consequently, different subsets of cells 
carrying antigens are recruited to inductive sites [18].
b. M cells, specialized cells in both internalizing and transportation of intestinal 
antigens [19]. The antigens are endocytosed or phagocytosed, transported in 
vesicles through the M cells cytoplasm, and released on the basal surface where 
they are captured by antigen-presenting cells and transported to inductive 
sites, which will be presented to T and B cells.
c. Lamina propria (LP) dendritic cells (CDs) can go through the epithelial cells to 
capture antigens directly from the intestinal lumen, preserving the epithelial 
barrier integrity [20].
It is well known that the intestinal epithelium provides a physical barrier that 
separates the trillions of commensal bacteria present into intestinal lumen from 
both underlying lamina propria and deeper intestinal layers. The intestinal epithe-
lium is composed of four cellular subsets derived from a common pluripotent stem 
cell progenitor: (1) enterocytes which constitute the majority of intestinal epithelial 
cells (IECs), (2) goblet cells producing mucus, (3) enteroendocrine cells producing 
hormones, and (4) Paneth cells that produce antimicrobial peptides and lectins. In 
addition, below the intestinal epithelium, stromal cells, B cells (especially plasma 
IgA producing cells), T cells, macrophages, and dendritic cells are found in lamina 
propria. In addition, strategically positioned are intraepithelial lymphocytes or 
iIELs (specialized T cells) and some dendritic cells, which are located between the 
IECs to sample the luminal content [20–22]. Thus, intraepithelial lymphocytes are 
considered the first line of cellular defense against any antigen that enters orally. 
The iIELs belong to the lymphoid tissue associated to intestine and they are found 
in a ratio of 1:10 with respect to the epithelial cells along 300 m2 of intestinal surface 
[23]. Most iIELs contain abundant cytoplasmic granules for cytotoxic activity; also, 
effector cytokines such as interferon gamma (IFN-γ), interleukin-2 (IL-2), IL-4, 
and IL-17 can be secreted [24, 25]. The iIELs are cells that provide an immediate and 
efficient immune protection to prevent the spread of pathogens. However, to avoid 
excessive or unnecessary inflammatory responses on intestinal barrier, the iIELs 
also have regulatory functions [26].
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3. Microbial ecosystem of the gastrointestinal tract
The human intestine contains a wide variety of microorganisms, approximately 
500–1000 different species, of which the Bacteria, Archaea and Eukarya are the 
principal ones [1, 27]. The predominant bacteria populations in the intestine are 
the Bacteroidetes and Firmicutes, constituting about 90% [28]. This diverse ecosys-
tem is called “gut microbiota,” which has a symbiotic and mutualism relationship 
with the host [29, 30]. The intestinal microbiota exerts its own functions and has 
both direct and indirect influence on host’s physiology and health, especially on 
metabolism. However, several pathologies, including neurological disorders such as 
irritable bowel syndrome, depression, anxiety, and Parkinson’s disease have been 
associated with alteration of the intestinal microbiota known as “dysbiosis” [5–7].
With respect to dysbiosis, the wide diversity and abundance of gut microbiota 
population can be modified importantly by host’s diet and age, as well as by other 
factors. The newborn is colonized by bacteria from birth and initially, there are 
no differences between bacteria population localized on different parts of body. 
Infants who are born via vaginal delivery are mainly colonized by Lactobacillus and 
Prevotella, microbial populations closely related to maternal vaginal bacteria popu-
lations [31]. In contrast, infants born by cesarean-section (C-section) are exposed 
to Staphylococcus and Corynebacterium, which are skin microbes [32]. Thus, vaginal 
delivery or cesarean section as well as lactation or weaning are important factors 
that influence intestinal microbiota establishment. On the other hand, initially it 
was proposed that the prenatal environment is sterile; however, the presence of 
several bacterial species has been detected on placentas, amniotic fluid, and in 
meconium of healthy mothers, which suggests that, in the intrauterine stage there is 
already contact with microbes [33]. The diversity and functionality of the bacterial 
ecosystem is modified and increased in subsequent years of childhood [33]. 
Thus, in adult life, the predominant populations are both Bacteroidetes and 
Firmicutes, while the phylum Actinobacteria, Proteobacteria, Verrucomincrobia, 
archaea, and eukaryotes decrease importantly [34, 35]. Commonly, intestinal 
microbiota is very stable in adulthood, although a greater proportion of both 
Bifidobacteria and Clostridia has been found in the gut of young adults in com-
parison with older adults [36]. Important changes in composition and function 
of intestinal microbiota occur on aging. Aging has been associated with changes 
in intestinal microbiota composition, inducing alterations of multiple physi-
ological functions, including intestine and immune system malfunctioning. An 
increased proportion of facultative anaerobes bacteria as well as an imbalance of 
Bacteroidetes/Firmicutes ratio in microbiota are age-related differences. Also, in 
people over 60 years of age, when the immune system function begins to decline, a 
significant decrease in Bifidobacteria has been found [37]. These previous findings 
were also supported by studies performed in intestinal mucosal tissue of aged and 
young mice, where a reduction in Akkermansia muciniphila proportion as well as 
decrease of antimicrobial factors Ang4 and lysozyme were detected in aged mice. 
Moreover, an important decrease in genes expression related to immunity was 
found, including T cell activation and other gene signaling pathways [38].
The high-carbohydrate and high-fat diet composition may produce dysbiosis. 
It was described that in mice, a Western diet (WD: high-carbohydrate and high-fat 
diet) intake caused dysbiosis and dysregulated bile acids (BA) synthesis with reduced 
endogenous ligands for BA receptors, that is, farnesoid X receptor and G-protein-
coupled bile acid receptor in the liver and brain [39]. More relevantly, a ketogenic low-
carbohydrate high-fat diet induced changes in the oral microbiome of elite endurance 
athletes; the relative abundances of Haemophilus, Neisseria, and Prevotella spp. were 
decreased, and the relative abundance of Streptococcus spp. was increased [40].
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3.1 Functions of the gut microbiota in the host
The main biological functions regulated by the gut microbiota are related to 
the efficiency to metabolize food and obtain energy. Polysaccharides are the main 
source of energy in bacterial metabolism, which are transformed into short-chain 
fatty acids (SCFAs). Bacterial metabolism is not limited only to SCFAs production 
and obtaining energy. The intestinal microbiota can synthesize several vitamins, 
aryl hydrocarbon receptor (AHR) ligands on host cells, polyamines [41], folate 
[42], indole [43], serotonin [44], and other compounds. In addition, intestinal 
microbiota also produces bacterial toxins called bacteriocins. To date, 13 species of 
bacteriocins have been found in human feces [45].
The major SCFAs produced by the gut microbiota are acetate, propionate, and 
butyrate, which are found at 80–130 mM [46, 47]. In this way, the SCFAs repre-
sent approximately 70% of the total energy captured by the intestinal epithelial 
cells. Interestingly, butyrate produced by Butyrivibrio fibrisolvens protects against 
autophagy and energy starvation in the epithelium of gnotobiotic mice [48, 49]. 
While acetate and propionate have an important role in lipid metabolism, activation 
of the Gpr43 receptor promotes adipogenesis [50]. Therefore, using antibiotics at 
subtherapeutic doses, as commonly used in animal production, a dysbiosis is gener-
ated by increasing SCFA levels, which consequently induces lipogenesis and hepatic 
triglycerides synthesis [50].
It is well known that microbiota strongly impacts on the expression of genes and 
proteins on host intestinal epithelial cells. In axenic mice, it has been found that in 
intestinal colonization by Bacteroides thetaiotaomicron, an important gene expression 
was induced. Expression of these genes is involved in protection, intestinal barrier 
function regulation, epithelium vascularization, and digestion/absorption of nutri-
ents by increasing amino acid metabolism [50, 51]. It also participates in the regula-
tion of endocrine, neurological, and bone density functions [33], as well as in the 
metabolism and absorption of phytochemicals such as polyphenols and drugs [50].
Additionally, several studies have shown that microbiota has an important 
role in peripheral and intestinal immune system ontogeny, as well as intestinal 
epithelium renewal [52, 53]. Also, microbiota-epithelial cell interaction indirectly 
controls the expenditure and storage of energy in the host [54]. Dysbiosis has been 
associated with a several pathologies affecting directly the digestive tract, including 
chronic inflammatory bowel diseases, colorectal cancer, constipation, and diar-
rhea; but in peripheral organs, it can also induce allergies, arthritis, or neurological 
disorders [55]. In this way, correcting the dysbiosis could improve the symptoms of 
diseases like irritable bowel syndrome (IBS) and functional diarrhea [56].
Intestinal bacteria are importantly involved in development and regulation of 
the immune system [57–59]. On this regard, mice grown under germ-free conditions 
exhibited several abnormalities, including hypoplastic Peyer’s patches, IgA-producing 
cells reduction, relatively poorly structured spleen and lymph nodes, and decrease in 
proportion of Treg cells in colon [53]. Interestingly, when mice were exposed to intestinal 
bacteria for several weeks, the structure and function of immune system cells were 
restored [60]. Moreover, it has been shown that lipopolysaccharides from gram negative 
bacteria, as well as peptidoglycans from gram positive bacteria, activate Toll-like recep-
tors (TLRs), inducing different immune responses [61]. Also, the expression of angio-
genin 4 by Bacteroides thetaiotaomicron is induced. Angiogenin 4 is an important immune 
response regulator with microbicidal activity against a wide range of intestinal microbes, 
including bacterial and fungal pathogens [62]. A zwitterionic capsular polysaccharide 
of Bacteroides fragilis is an antigen related to T CD4 + effector cells function [63]; it also 
protects mice from Helicobacter hepaticus infections by suppressing IL-17 production and 
other immunological mechanisms [64]. Moreover, the genus Bifidobacteria is a producer 
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of acetate that inhibits the translocation of Shiga toxin from E.coli 0157 suppressing 
colon inflammation [65]. In addition, Bacteroides, Turicibacter, and Barnesiella bacteria 
strains interact with T CD8 + cytotoxic cells in the mucosal compartment of both the 
small intestine and the colon [66]. Finally, the gut microbiota also regulates the interac-
tion of dendritic cells with regulatory T cell through TLR 2 signaling, which induces an 
increased susceptibility to chronic inflammatory diseases such as colitis [67].
3.2 Host’s immunomodulatory activity on the gut microbiota
The interactions between environmental signals and intestinal immune system 
are necessary to maintain a stable equilibrium and regulate the protective function 
of the intestinal barrier. Thus, in order to prevent microbial colonization and tran-
sepithelial migration, several chemical substances are produced by the intestinal 
epithelial cells, such as gastric acid, enzymes (lactoferrin, lysozyme), antimicrobial 
peptides (defensins), mucins, and nitric oxide [68]. On the other hand, signaling 
through Toll-like receptors (TLRs) is very important for the activation of innate 
immune system. TLRs recognize a wide range of common antigens present in 
pathogens, activating the adaptive immune system for the generation of multiple 
highly specific and immunocompetent clones [69].
4.  Connection between enteric nervous system (ENS) and central 
nervous system (CNS)
The enteric nervous system (ENS) extends from the esophagus to the anal 
region. The main functions are: (1) stimulation of glandular secretions, (2) motor 
functions such as peristalsis, and (3) ions and water exchange. The neurons found 
in CNS are subdivided into two main plexuses: the myenteric plexus and the submu-
cosal plexus [70]. The former is responsible for peristalsis and second regulates the 
glandular secretions and control of blood flow. There are extrinsic fibers connecting 
these two plexuses, which are stimulated by both sympathetic and parasympathetic 
nervous system, communicating directly to spinal cord, part of the vagus nerve, 
and pre-vertebral ganglia of the sympathetic nervous system, although the ENS is 
able to function independently [71].
Generally, there are different types and subtypes of neurons throughout the 
ENS: excitatory neurons of the intestine, secretomotor, vasodilator, and non-vaso-
dilator; some of them innervate whole endocrine cells and others intrinsic visceral 
afferent neurons. Most of the different types of neurons participate in reflexes 
corresponding to each plexus (myenteric and submucosal) (Figure 3).
The neurotransmitters secreted by enteric neurons are varied, the acetyl-
choline (excitatory effect) and noradrenaline (inhibitory effect) being the most 
studied [72]. In addition, the communication of the ENS with the CNS is not only 
through the secretion of these neurotransmitters. Several studies have shown that 
bacterial metabolites generated in the intestinal ecosystem have a direct impact on 
the brain. Thus, it is well known that the intestinal microbiota has an important 
effect on CNS, because the homeostasis and intestinal functions can be regulated 
by the CNS [73]. The CNS and intestine connection may occur through several 
pathways, including: neuronal, hormonal, immune system, and intestinal bacte-
rial metabolites [74]. Regarding the neuronal connection, the intestine is directly 
connected to the brain through the vagus nerve; thus, intestinal microbiota may 
stimulate the enteric nervous system [75]. In addition, several reports have shown 
that a defective communication between the brain and intestine microbiota is 
associated to anxiety, depression, inflammatory bowel disease, and other diseases 
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[76–78]. Interestingly, behavior changes in elderly have been associated with 
decreased immune function, resulting in alteration of intestinal microbiota-brain 
connection [79].
4.1 Dysbiosis and its effect on the neuroplasticity and behavior
In the first weeks of life, microbiota diversifies into a microbial community 
in which anaerobic microorganisms predominate [80]. This early colonization 
coincides with hypothalamic-pituitary-adrenal (HPA) axis activation, which has 
an important role in the innervation of the gastrointestinal (GI) tract and enteric 
nervous system (ENS) function. Likewise, the production of 5HT by enterochro-
maffin cells is regulated by the intestinal microbiota, inducing de novo synthesis of 
5HT [44].
Several reports have shown the relation between intestine and the CNS through 
metabolic, neuroendocrine, and immunological pathways, impacting neuronal 
plasticity and cognition. Production of proinflammatory cytokines (IL-1) in intes-
tinal lumen may affect the brain through vagus nerve [81]. Also, bacterial products 
like lipopolysaccharide (LPS) can increase cytokines production, as well as induce 
both neuroinflammation and neurodegeneration [82]. In addition, it was shown 
that WD-fed mice had intestinal dysbiosis, which was accompanied by inflam-
matory signaling in the brain, microglial activation, and reduced neuroplasticity 
[83]. Therefore, dysbiosis of gut microbiota may increase the cytokines production 
and neuroinflammation, affecting mood, or it could induce psychiatric disorders 
such as depression and anxiety as was described in animal models [56] as well as in 
comparative studies performed in humans [5, 84]. Moreover, in maternal immune 
activation (MIA) mouse model, intestinal dysbiosis induced both higher production 
of both 4-ethylphenylsulfate (4EPS) and indolepyruvate, leading to autism spec-
trum disorder (ASD). Interestingly, with Bacteroides fragilis administration, these 
behavioral symptoms were ameliorated [85].
Figure 3. 
Structure of the enteric nervous system. Both plexuses can be identified (myenteric and submucosal). The 
extension goes from the intestinal wall to the enteric plexuses and from there to the pre-vertebral ganglia of the 
spinal cord and brainstem. SNS, sympathetic nervous system; PSNS, parasympathetic nervous system.
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A mechanism by producing substrates from bacterial metabolism such as SCFAs 
from the fermentation of dietary fiber has been described. The SCFAs regulate the 
metabolism of glucose and cholesterol [86]. Most importantly, the SCFAs (acetate, 
propionate, and butyrate) treatment alleviated the psychosocial stress-induced 
alterations in mice; the effect observed was selective, because the stress-induced body 
weight gain, fecal SCFAs, and the colonic gene expression of the SCFAs receptors free 
fatty acid receptors 2 and 3 remained unaffected by SCFAs supplementation [87].
Other studies also have shown that dysbiosis may induce mood alterations. For 
example, dysbiosis induced by antibiotics treatment in mice leads to cognitive and 
behavioral alterations as well as to neurological changes [88, 89]. In addition, in juvenile 
mice with dysbiosis, after a 2-week antibiotic treatment, the levels of mRNA and 
protein of brain-derived neurotrophic factor (BDNF) and tropomyosin-related recep-
tor kinase B (TrKB) in hippocampus CA3 and dentate gyrus subregions, respectively, 
significantly increased [89]. Most importantly, patients with disorders like depression, 
anxiety, and eating disorder psychopathology have a significantly lower microbial alpha 
diversity as compared with healthy subjects [5]. Interestingly, depression and anxiety 
symptoms may be improved by fecal microbiota transplantation in patients with 
irritable bowel syndrome (IBS), functional diarrhea (FDR), or functional constipation 
(FC). Thus, the increase of microbiota diversity may improve the patient’s mood [56].
5. Prebiotics
Since its initial description in 1995, the concept of prebiotic has been in constant 
evolution. Currently, according to Gibson and Roberfroid, a probiotic has been 
defined as “any substance present in diet, which specifically stimulates the growth 
and/or the fermentative activity of one or a limited number of bacteria species of 
intestinal microbiota, generating beneficial effects on health of host as a conse-
quence of changes on either bacterial composition or metabolic activity” [90].
Generally, a food ingredient is considered as a prebiotic when it has the fol-
lowing characteristics: (a) it must be kept in good condition until reaching the 
distal portions of the intestine; that is, it is not absorbed in the anterior part of the 
gastrointestinal tract and resists the hydrolysis of digestive enzymes [91] such as 
α-glucosidase, maltase, isomaltase, and sucrase [92]; (b) it must act as a selective 
substrate in the growth and/or metabolism of one or a limited number of beneficial 
bacterial species, such as Lactobacillus spp. and Bifidobacterium spp.; and finally (c) 
it must positively stimulate the microbiota, by increasing beneficial microorgan-
isms and reducing pathogenic bacteria [93].
It is well known that proliferation of bifidobacteria and lactobacilli is favored 
by prebiotics; moreover, the proliferation of bacterial pathogenic strains such as 
Clostridium, Escherichia, Campylobacter, Enterobacterium, or Salmonella is inhibited. 
It has been proposed that intestinal microbiota is in involved in inhibition prebiotics 
mechanisms, by either competition for adhesion sites to the mucosa, or changes in 
the intestinal environment, such as (a) a reduction in pH as result of the synthesis 
of SCFA and (b) production of metabolites inhibiting pathogens proliferation, such 
as bacteriocins [94].
5.1 Types and sources
As already mentioned, prebiotics are normally ingested in the diet; however, 
only some carbohydrates (poly and oligosaccharides), whose chemical structure has 
β-type bonds, some peptides, some proteins, and certain lipids such as esters and 
ethers are food ingredients qualified as prebiotics [95].
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Different types of oligosaccharides considered as prebiotics have been 
reported, among them are: fructooligosaccharides (FOS), oligofructose (OF), the 
inulin type fructans (ITFs), galactooligosaccharides (GOS), transgalactooligo-
saccharides (TOS), and lactulose. However, there are others less known such as 
isomaltooligosaccharides (IMOS). Xylooligosaccharides (XOS) and mananooligo-
saccharides (MOS) also have a probiotic potential [90, 95]. It is well known that 
sucrose and starch are the main carbohydrates found in higher plants, followed by 
glucomannans and fructans are the main reserve sources in the vegetable kingdom 
[96, 97].
5.2 Interaction of prebiotics in gut microbiota
The non-digestible carbohydrates or prebiotics are selectively fermented by 
the microbiota that produces important metabolites for the health of the host, the 
SCFAs acetate, propionate, and butyrate mainly. Likewise, prebiotics have a direct 
impact on the gut-associated lymphoid tissue (GALT) with immunomodulatory 
functions [98]. The symbiotic association between the host and the microbiota is 
fundamental in its physiology. The increase of the beneficial populations in the 
intestinal lumen affects the establishment of opportunistic pathogens, contributing 
to the strengthening of the GALT.
5.3 Potential effects on microbiota-GALT-brain axis
The stimulation of probiotic bacteria by prebiotics contributes to the increase of 
the production of beneficial metabolites for the host, such as the SCFAs. However, 
prebiotics not only have an impact on the intestinal microbiota. Oligofructose, an 
inulin type fructan, can bind to cellular receptors of pathogenic bacteria and block 
adhesion to the surface of enterocytes, helping to prevent colonization. In the same 
way, β (2→1)-fructans are ligands of TLR2, TLR4, TLR5, TLR7, TLR8, and NOD2. 
Moreover, levan (2→6)-fructans appears to be a recognized of TLR4 to reduce 
IgE serum levels and Th2 responses [98]. Bacterial metabolites travel through the 
vagus nerve to reach specific brain regions such as cerebellum and hippocampus 
and modify gene expression [99]. It has been described that alterations in intestinal 
microbiota due to exposure to chronic stress are reversed with the administration of 
prebiotics and/or probiotics [100].
According to the classification of microbiota obtained by statistical analysis of 
sequence data, an alpha diversity has been identified, which describes the diversity 
of bacteria within a single individual; while beta diversity describes the diversity of 
specimens between different individuals. It has been shown that different types of 
prebiotics have an effect on the microbiota-GALT-brain axis in mice and human 
models. Prebiotics treatments (isolated from acorn and sago) induced increased 
β-diversity in heart failure patient’s fecal microbiome, while no significant change in 
β-diversity was seen in healthy fecal microbiome. Alpha diversity was significantly 
higher in both healthy and diseased fecal microbiome, which was accompanied with 
an increase of the beneficial bacteria and SCFAs. Moreover, prebiotics treatment 
ameliorated HFD-induced glucose intolerance and insulin resistance in diabetic 
mice. Feeding both prebiotics treatments and inulin increased SCFAs levels in the 
mouse gut, and decreased the gut hyperpermeability and mucosal inflammatory 
markers in HFD-fed mice. The expression of pro-opiomelanocortin was also modu-
lated by prebiotics administration, suggesting an important role in the hypotha-
lamic energy signaling in the mice [101]. In diabetic db/db mice, the administration 
of oligofructose increases the expression of tight junction proteins occludin and 
ZO-1, which improves the integrity of the BBB in the hypothalamus and normalizes 
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the expression of mRNA of IL-6 in the hippocampus; however, it does not improve 
alterations in behavior or in neurogenesis [102].
Moreover, the administration of prebiotic chitosan oligosaccharides (COSs) in 
Male Sprague-Dawley rats increases cognitive function and reduces levels of TNF-α 
and IL-1β, both pro-inflammatory cytokines [103]. In a mouse model of amyo-
trophic lateral sclerosis, the oral administration of GOS reduced the motor neuron 
death and muscular atrophy and increased the levels of serum folate, vitamin B12, 
and homocysteine [104]. In the same way, in a mouse model with lipopolysac-
charide-induced anxiety, the administration of bimuno-galacto-oligosaccharides 
(B-GOSs) reduced the pro-inflammatory cytokine IL-1β and expression of cortical 
5-HT2A receptors [78]. In a mouse model of vascular dementia, the β-glucan from 
barley and arabinoxylan from the yeast Triticum aestivum demonstrated a protective 
effect [105].
Interestingly, our research group previously demonstrated that the administra-
tion of oligofructose and Agave fructans decreased TBARS levels and carbonyls in 
learning and memory regions of the brain of overweight mice [106]. Also, in high-
fat diet-induced obese mice, prebiotics not only reduces the oxidative damage in the 
same regions but also increases the levels of BDNF and GDNF [107].
On the other hand, the administration of synbiotics (probiotics and prebiotics 
in combination) shows interesting effects. In infants with cow’s milk allergy, the 
treatment with based formula of amino-acid and symbiotics (a combination of 
fructo-oligosaccharides and Bifdobacterium breve M-16V) increased Bifidobacterium 
spp. and Veillonella sp bacteria substantially. Additionally, the lactate levels were 
increased, but the valerate and SCFAs levels were decreased [108]. Prolonged 
consumption of ADR-159 diet (fermentate generated from Lactobacillus fermentum 
and Lactobacillus delbrueckii) had no effect on anthropometrics or general health, 
but mice fed with ADR-159 presented increased sociability and lower baseline 
corticosterone levels (stress hormone). The diet also induced significant changes in 
the microbiota [109].
In patients with major depressive disorder (MDD), probiotics treatment 
(≥10 × 109 CFU of freeze-dried Helveticus R0052 and B. longum R0175 bacteria) for 
8 weeks improved depression symptoms, but the serum inflammatory cytokines 
marker (TNF-α, IL-1β, IL-6, and IL-10) levels were not improved, and the urinary 
cortisol levels decreased by 20% of baseline. However, the prebiotics treatment 
(galactooligosaccharides, GOS) had no effect on depression symptoms nor inflam-
matory marker levels [110]. In a like manner, oral GOS administration reduced 
the human stress hormone cortisol and increased attentional vigilance to positive 
versus negative stimuli [111].
6. Conclusions
The effect of the probiotics on the intestinal microbiota is quite important not 
only for the functions on intestine, but also for the development and function of 
immune system, metabolism, and central nervous system. Moreover, these systems 
are closely related, so that any alteration will impact their functionality. Therefore, 
the balance on microbiota-gut-central nervous system axis is very important to 
maintain the adequate functions of these systems.
Intestinal dysbiosis leads to alterations in development and function of central 
nervous system, which is significantly improved upon intestinal colonization with 
normal microbiota and probiotics treatment. To date, the interaction of microbiota-
intestine-brain axis is not completely clear. For this reason, it is interesting to redi-
rect the investigation of CNS diseases whose pathological mechanism is unknown.
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